Scientia Advisors - Science, knowledge and skill for your competitive advantage

LinkedIn Facebook Twitter Delicious

Therapeutics

Although significant challenges exist in therapeutics markets, there are significant opportunities for companies that can adapt to the ever-changing healthcare landscape.

Some of the greatest opportunities reside in biologic therapies, personalized medicine, and emerging economies. At Scientia, we work with large pharmaceutical, biotech, specialty pharmaceutical, contract manufacturers and drug delivery companies to successfully navigate the impact of disruptive change on their business, and help them outperform their peers and position themselves for future growth.


Industry Briefings

October 05, 2011
The New Battleground For Novel Diabetic Agents: Incremental Cost-Effectiveness Ratio
Jeff Stoll

July 25, 2011
Concurrent Dx/Rx Review Will Require More Collaboration at FDA and More Outreach by Industry

May 15, 2011
Demand Escalates for iPSC Life Science Tools: Induced Pluripotent Stem Cells Prove Invaluable in Toxicity and Drug Efficacy Screening
Lisa Carey and Michael Tapella


Related Blog Posts

January 9, 2012
New Questions Emerge in Stratified (Personalized) Medicine

December 6, 2011
Value Creation for Life Sciences Tools Companies in a Rapidly Changing Marketplace


Industry Reviews

June 02, 2010
Assessing the Biopharmaceutical Market: Promises and Challenges

November 04, 2009
The Evolving Cosmeceuticals Market:
How science is changing the standards of personal care

October 13, 2009
Rethinking Insulin:
The Changing Diabetes Treatment Landscape


Scientia in the News

February 10, 2012
Pharmalot interview with Jonathan Pan on Biosimilar Guidance

January 03, 2012
Harry Glorikian interviewed by partneringNEWS in "partnering spotlight"

December 27, 2011
BioPharm Insight quotes Jonathan Pan in article "Astellas to cut R&D costs with in-house focus though still pursuing oncology candidates; well-placed for mid-size acquisitions"


Press Releases

February 06, 2012
Scientia Advisors Announces Meghan Needham as Director of Marketing

November 16, 2010
Scientia Advisors Appoints Patrick Terry, Principal of New Pricing and Reimbursement/Market Access Practice

October 28, 2010
Scientia Advisors Announces Launch of ScientiaAdvisors Blog

Scientia Leaders »

Harry Glorikian »
Founder and Managing Partner

Arshad Ahmed »
Founding Partner

Patrick Terry »
Principal


Upcoming Conferences

May 29, 2012
Patrick Terry Speaking at Genome-wide Partnering & Dealmaking Conference


CONSULTING CAPABILITIES »

Scientia Advisors consulting capabilities are the result of the skills and expertise of highly talented individuals who have years of experience in the life science and healthcare industries.

View our Consulting Capabilities »

SCIENTIA ADVISORS, LLC  |  info@scientiaadv.com


55 Cambridge Parkway, Suite 300E, Cambridge MA 02142  |  Phone: 617-299-3000  |  Fax: 617-812-0315

© 2012 Scientia Advisors LLC